AMGEN: Otezla HCP
Otezla is the #1 prescribed pill to treat plaque psoriasis and also treats psoriatic arthritis. It works inside your body to reduce the inflammation that causes joint pain and swelling.
Concept: Arresting decay
This concept highlights the urgency of heading off PsO and PsA disease progression
at the pass. It draws to different, striking metaphorical imagery that would help set us apart from
our competitors in the space.
Concept: Words to live by
This concept spotlights the power of the physician and their beliefs, framing them in a portrait style as
thinkers and leaders in the space.
AMGEN: Otezla DTC
Concept: It's personal
Otezla gets into your psyche, helping to alleviate your inner insecurities. Once you've broken the physical and emotional cycle of psoriatic disease, you can take that leap towards feeling and acting like your true self.
BRAND X
Concept: New Light
Brand X enhances ER degradation with advanced PROTAC technology, and allows you to see
2L mBC treatment differently.
Amgen: Tavneos Concept 1
Concept: Okay is not okay
With metaphorical disasters juxtaposed with defeated, accepting patients, this concept drives home the urgency of no longer tolerating the grim realities of ANCA-AAV and conventional treatment.
Amgen: Tavneos Concept 2
Concept: Bridge the gap
This concept brings the ANCA-AAV patient need to life by illustrating the long-ignored chasm
between patient and physician goals.
sanofi: synvisc_HCP
SYNVISC® (hylan G-F 20) and SYNVISC-ONE® (hylan G-F 20) are indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients and can provide patient up to six months of OA knee pain relief
with a single injection.
Concept: From Slow to Go
For people with OA of the knee, the aches and pains can pull back the reigns on life and stop them in their tracks.
It all becomes too hard. Synvisc can get them restarted in a big way.
